BioLine RX Ltd - ADR

General ticker "BLRX" information:

  • Sector: Health Care
  • Industry: Biotechnology
  • Capitalization: $19.8M

BioLine RX Ltd - ADR does not follow the US Stock Market performance with the rate: -35.9%.

Estimated limits based on current volatility of 2.6%: low 0.19$, high 0.21$

Factors to consider:

  • Current price 81.4% below estimated low
  • Earnings for 9 months up through Q3 exceed our estimates

Stock Forecast*

* forecast is subjective and experimental, should not be used for any investment decisions

Long term estimates were made for the period from 2023-12-31 to 2025-12-30

  • 2023-12-31 to 2024-12-30 estimated range: [1.19$, 2.83$]
  • 2024-12-30 to 2025-12-30 estimated range: [1.53$, 3.35$]

Financial Metrics affecting the BLRX estimates:

  • Negative: Non-GAAP EPS, $ of -0.90 <= 0.10
  • Negative: Operating profit margin, % of -91.19 <= 1.03
  • Negative: negative Net income
  • Negative: Operating cash flow per share per price, % of -17.98 <= 2.35
  • Negative: Industry operating cash flow per share per price (median), % of -23.87 <= 3.85

Similar symbols

Short-term BLRX quotes

Long-term BLRX plot with estimates

Financial data

YTD 2021-12-31 2022-12-31 2023-12-31
Operating Revenue $0.00MM $0.00MM $4.80MM
Operating Expenses $24.78MM $29.16MM $54.49MM
Operating Income $-24.78MM $-29.16MM $-49.69MM
Non-Operating Income $-2.28MM $4.21MM $-10.92MM
Interest Expense $0.98MM $2.16MM $2.17MM
R&D Expense $19.47MM $17.63MM $12.52MM
Income(Loss) $-27.05MM $-24.95MM $-60.61MM
Taxes $1.09MM $-6.08MM $0.00MM
Profit(Loss) $-28.14MM $-18.87MM $-60.61MM
Stockholders Equity $68.09MM $50.84MM $13.22MM
Inventory $0.00MM $41.22MM $1.95MM
Assets $81.39MM $76.38MM $63.92MM
Operating Cash Flow $-23.57MM $-26.24MM $-22.61MM
Capital expenditure $0.10MM $0.32MM $0.30MM
Investing Cash Flow $-38.22MM $4.01MM $1.44MM
Financing Cash Flow $57.75MM $20.44MM $15.06MM
Earnings Per Share* $-0.64 $-0.37 $-0.94

* EPS are Split Adjusted, recent splits may be reflected with a delay.